Daniil Gataulin
Stock Analyst at Chardan Capital
(3.96)
# 746
Out of 4,947 analysts
104
Total ratings
46.74%
Success rate
12.21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FBRX Forte Biosciences | Maintains: Buy | $61 | $11.57 | +427.23% | 6 | Aug 15, 2025 | |
| ZURA Zura Bio | Maintains: Buy | $10 | $1.66 | +502.41% | 1 | Aug 15, 2025 | |
| OTLK Outlook Therapeutics | Maintains: Neutral | $3 | $2.34 | +28.21% | 9 | Aug 15, 2025 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $35 | $8.17 | +328.40% | 5 | Aug 15, 2025 | |
| TRML Tourmaline Bio | Maintains: Buy | $70 | $22.57 | +210.15% | 3 | Aug 14, 2025 | |
| ADVM Adverum Biotechnologies | Maintains: Buy | $33 | $2.86 | +1,053.85% | 8 | Aug 13, 2025 | |
| CRVO CervoMed | Maintains: Buy | $15 | $10.12 | +48.22% | 7 | Aug 11, 2025 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $8.82 | +489.57% | 12 | Aug 8, 2025 | |
| CGTX Cognition Therapeutics | Maintains: Buy | $4 | $1.54 | +159.74% | 8 | Aug 8, 2025 | |
| EYPT EyePoint Pharmaceuticals | Maintains: Buy | $27 | $11.09 | +143.46% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 | $1.05 | +566.67% | 13 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $35 | $16.18 | +116.32% | 5 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.42 | - | 5 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $33 | $17.90 | +84.36% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $2.31 | +9,423.81% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.57 | - | 2 | Jul 25, 2023 |
Forte Biosciences
Aug 15, 2025
Maintains: Buy
Price Target: $61
Current: $11.57
Upside: +427.23%
Zura Bio
Aug 15, 2025
Maintains: Buy
Price Target: $10
Current: $1.66
Upside: +502.41%
Outlook Therapeutics
Aug 15, 2025
Maintains: Neutral
Price Target: $3
Current: $2.34
Upside: +28.21%
MeiraGTx Holdings
Aug 15, 2025
Maintains: Buy
Price Target: $35
Current: $8.17
Upside: +328.40%
Tourmaline Bio
Aug 14, 2025
Maintains: Buy
Price Target: $70
Current: $22.57
Upside: +210.15%
Adverum Biotechnologies
Aug 13, 2025
Maintains: Buy
Price Target: $33
Current: $2.86
Upside: +1,053.85%
CervoMed
Aug 11, 2025
Maintains: Buy
Price Target: $15
Current: $10.12
Upside: +48.22%
REGENXBIO
Aug 8, 2025
Maintains: Buy
Price Target: $52
Current: $8.82
Upside: +489.57%
Cognition Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $1.54
Upside: +159.74%
EyePoint Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $27
Current: $11.09
Upside: +143.46%
Aug 4, 2025
Maintains: Buy
Price Target: $7
Current: $1.05
Upside: +566.67%
Jul 29, 2025
Maintains: Buy
Price Target: $38 → $35
Current: $16.18
Upside: +116.32%
Jul 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.42
Upside: -
May 9, 2025
Maintains: Buy
Price Target: $28 → $33
Current: $17.90
Upside: +84.36%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $2.31
Upside: +9,423.81%
Jul 25, 2023
Downgrades: Neutral
Price Target: n/a
Current: $10.57
Upside: -